论文部分内容阅读
白术前景看好行情:今年以来,药市上的白术库薄销畅,价曾升为:浙白术15～16元,亳白术13～14元,河北产一年生小白术8～9元。分析:白术价升的主要原因:1.种植面积减少。2001～2002年白术产量增卖价低,术农收入减少,只好减少种植面积。浙江、安徽生产区2003年比2002年种植的白术收成减少5～6成以上。其它次产区因改种为茶叶、花生等,也程度不同地减产或绝种。加上2003年旱涝灾害,和4.5月的“非典”流行,白术中成药投料用量消耗,使
Atractylodes prospects Quotes: Since this year, the pharmaceutical market Atractylodes thin sales Chang, the price has risen to: Zhejiang Atractylodes 15 to 16 yuan, Atractylodes 13 to 14 yuan, Hebei annual annual Atractylodes 8 to 9 yuan. Analysis: Atractylodes price rise of the main reasons: 1. Decrease in planting area. From 2001 to 2002, the production and sales price of Atractylodes macrocephala rose at a low price, and the income of agricultural technicians was reduced, so that the planted area was reduced. Zhejiang, Anhui production area in 2003 than in 2002 to reduce the crop harvest Atractylodes more than 5 to 6 into. Other secondary producing areas due to re-planting for tea, peanuts, but also to different degrees to cut or extinct. Coupled with the droughts and floods in 2003 and the epidemic of SARS in April and May, the consumption of Chinese traditional medicine in Atractylodes macrocephala consumes